BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7867594)

  • 1. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060.
    Mathieu C; Waer M; Casteels K; Laureys J; Bouillon R
    Endocrinology; 1995 Mar; 136(3):866-72. PubMed ID: 7867594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A.
    Casteels KM; Mathieu C; Waer M; Valckx D; Overbergh L; Laureys JM; Bouillon R
    Endocrinology; 1998 Jan; 139(1):95-102. PubMed ID: 9421403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.
    Casteels K; Waer M; Laureys J; Valckx D; Depovere J; Bouillon R; Mathieu C
    Transplantation; 1998 May; 65(9):1225-32. PubMed ID: 9603172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes.
    Casteels K; Waer M; Bouillon R; Depovere J; Valckx D; Laureys J; Mathieu C
    Clin Exp Immunol; 1998 May; 112(2):181-7. PubMed ID: 9649179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogens inhibit in vitro bone resorption stimulated by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogs EB1089 and KH1060.
    Vink-van Wijngaarden T; Birkenhäger JC; Kleinekoort WM; van den Bemd GJ; Pols HA; van Leeuwen JP
    Endocrinology; 1995 Feb; 136(2):812-5. PubMed ID: 7835315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of several metabolites of the vitamin D analog 20-epi-22-oxa-24a,26a,27a-tri-homo-1,25-(OH)(2) vitamin D(3) (KH 1060) to the overall biological activity of KH1060 by a shared mechanism of action.
    van den Bemd GC; Dilworth FJ; Makin HL; Prahl JM; Deluca HF; Jones G; Pols HA; van Leeuwen JP
    Biochem Pharmacol; 2000 Mar; 59(6):621-7. PubMed ID: 10677578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3.
    Mathieu C; Waer M; Laureys J; Rutgeerts O; Bouillon R
    Diabetologia; 1994 Jun; 37(6):552-8. PubMed ID: 7926338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice.
    Gysemans CA; Cardozo AK; Callewaert H; Giulietti A; Hulshagen L; Bouillon R; Eizirik DL; Mathieu C
    Endocrinology; 2005 Apr; 146(4):1956-64. PubMed ID: 15637289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice.
    Mathieu C; Laureys J; Sobis H; Vandeputte M; Waer M; Bouillon R
    Diabetes; 1992 Nov; 41(11):1491-5. PubMed ID: 1397723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro.
    Sandler S; Buschard K; Bendtzen K
    Immunol Lett; 1994 Jun; 41(1):73-7. PubMed ID: 7959906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic analogue of vitamin D3, 22-oxa-1 alpha,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice.
    Abe J; Takita Y; Nakano T; Miyaura C; Suda T; Nishii Y
    Endocrinology; 1989 May; 124(5):2645-7. PubMed ID: 2539984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in NOD mice when given early and long term.
    Takiishi T; Ding L; Baeke F; Spagnuolo I; Sebastiani G; Laureys J; Verstuyf A; Carmeliet G; Dotta F; Van Belle TL; Gysemans CA; Mathieu C
    Diabetes; 2014 Jun; 63(6):2026-36. PubMed ID: 24550187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vitamin D analog, KH1060, is rapidly degraded both in vivo and in vitro via several pathways: principal metabolites generated retain significant biological activity.
    Dilworth FJ; Williams GR; Kissmeyer AM; Nielsen JL; Binderup E; Calverley MJ; Makin HL; Jones G
    Endocrinology; 1997 Dec; 138(12):5485-96. PubMed ID: 9389535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-Dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats.
    Burnatowska-Hledin MA; Doyle TM; Eadie MJ; Mayor GH
    J Lab Clin Med; 1986 Aug; 108(2):96-102. PubMed ID: 3755457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxy-24-OXO-16ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo.
    Lemire JM; Archer DC; Reddy GS
    Endocrinology; 1994 Dec; 135(6):2818-21. PubMed ID: 7988477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial prevention of active Heymann nephritis by 1 alpha, 25 dihydroxyvitamin D3.
    Branisteanu DD; Leenaerts P; van Damme B; Bouillon R
    Clin Exp Immunol; 1993 Dec; 94(3):412-7. PubMed ID: 8252801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: synergy with cyclosporine.
    Mathieu C; Laureys J; Waer M; Bouillon R
    Transplant Proc; 1994 Dec; 26(6):3128-9. PubMed ID: 7998092
    [No Abstract]   [Full Text] [Related]  

  • 19. [1,25-dihydroxyvitamin D3: the endocrine system meets the immune system].
    Mathieu C; Decallonne B; van Etten E
    Verh K Acad Geneeskd Belg; 2002; 64(1):71-80; discussion 80-2. PubMed ID: 11995203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D3 in combination with cyclosporin A.
    Casteels K; Waer M; Bouillon R; Allewaert K; Laureys J; Mathieu C
    Transplant Proc; 1996 Dec; 28(6):3095. PubMed ID: 8962198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.